The incidence of sore throat and group A streptococcal pharyngitis in children at high risk of developing acute rheumatic fever: A systematic review and meta-analysis

• Published in: PloS one Vol. 15; no. 11; p. e0242107
• Main Authors: Pearce, Sarah, Bowen, Asha C, Engel, Mark E, de la Lande, Maya, Barth, Dylan D
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 18.11.2020; Public Library of Science (PLoS)
• Subjects: Aboriginal Australians; Adolescent; Antigens; Biology and Life Sciences; Cardiovascular diseases; Child; Child, Preschool; Children; Complications and side effects; Confidence intervals; Coronary artery disease; Demographic aspects; Developed countries; Diagnosis; Disease prevention; Epidemiology; Female; Fever; Grey literature; Health aspects; Health risks; Heart diseases; Humans; Incidence; Income; Infant; Infectious diseases; Male; Medical research; Medicine and Health Sciences; Meta-analysis; Pathogenesis; People and Places; Pharyngitis; Pharyngitis - complications; Pharyngitis - epidemiology; Pharynx; Physical Sciences; Research and Analysis Methods; Reviews; Rheumatic fever; Rheumatic Fever - epidemiology; Rheumatic heart disease; Risk; Risk factors; Social Sciences; Sore throat; Streptococcus; Streptococcus infections; Systematic review; Vaccines; Australia; Western Australia Australia
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0242107

Group A streptococcal (GAS) pharyngitis has traditionally been considered the sole precursor of acute rheumatic fever (ARF). Evidence from Australia, however, suggests that GAS skin infections may contribute to the pathogenesis of ARF. A missing piece of evidence is the incidence of sore throat and GAS pharyngitis in this setting. We conducted a systematic review and meta-analysis of the incidence of sore throat and GAS pharyngitis in all children at risk of developing ARF. Databases were systematically searched for studies reporting on the incidence of pharyngitis among children from low to upper-middle income countries, and Indigenous children living in high-income countries. Studies were subjected to data extraction by two independent reviewers. Following an assessment of the methodological quality of the studies, we extracted incidence rates (IRs) and conducted a meta-analysis. This systematic review is registered on PROSPERO (CRD42019113019). From 607 titles identified by the search, 11 articles met the predetermined inclusion criteria; ten studies reported IRs while for the remaining study, the incidence was calculated. The pooled incidence estimated for sore throat was 82.5 per 100 child-years (95% confidence interval [CI], 6.5 to 1044.4 per 100 child-years, I2 = 100%) and GAS pharyngitis was 10.8 per 100 child-years (95% CI, 2.3 to 50.0 per 100 child-years, I2 = 99.9%). The pooled IRs for sore throat in children at risk of developing ARF were higher than rates reported in developed nations (32.70-40 per 100 child-years) and similar for GAS pharyngitis (12.8-14 per 100 years). The limited Australian data lend support to the need for further studies to inform the role of GAS pharyngitis in the development of ARF in Australian Indigenous children, so as to inform local primary prevention strategies for ARF and Rheumatic Heart Disease (RHD).